12:00 AM
Oct 27, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Altrazeal Silver: Pivotal trial started

Uluru began a U.S. pivotal trial to compare Altrazeal Silver vs. a marketed silver-containing carboxymethylcellulose dressing in 40...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >